Watch the Dallas Symposium LIVE, and fundraiser auction
Ticket proceeds support mindat.org! - click here...
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2013, October) Reactions Weekly Vol. 1472 (1) Springer Science and Business Media LLC

Advanced
   -   Only viewable:
Reference TypeJournal (issue)
JournalReactions Weekly
Year2013 (October)Volume1472
Issue1
PublisherSpringer Science and Business Media LLC
Mindat Ref. ID13306537Long-form Identifiermindat:1:5:13306537:6
GUID0
Full Reference(2013, October) Reactions Weekly Vol. 1472 (1) Springer Science and Business Media LLC
Plain Text(2013, October) Reactions Weekly Vol. 1472 (1) Springer Science and Business Media LLC
In(2013) Reactions Weekly Vol. 1472. Springer Science and Business Media LLC

Contains

(2013) Digoxin use increases mortality risk in patients with systolic HF. Reactions Weekly, 1472 (1) 1 doi:10.1007/s40278-013-6222-8
(2013) FDA mandates labelling colour change for fentanyl patch. Reactions Weekly, 1472 (1) 2 doi:10.1007/s40278-013-6223-7
(2013) MHRA looks to simplify incident reporting. Reactions Weekly, 1472 (1) 2 doi:10.1007/s40278-013-6224-6
(2013) WHO calls for post-reg surveillance to be part of African initiative. Reactions Weekly, 1472 (1) 2 doi:10.1007/s40278-013-6225-5
(2013) Rituximab, ofatumumab boxed warning of HBV reactivation risk. Reactions Weekly, 1472 (1) 3 doi:10.1007/s40278-013-6226-4
(2013) New boxed warning for Tygacil. Reactions Weekly, 1472 (1) 3 doi:10.1007/s40278-013-6227-3
(2013) Aggression with tapentadol, an apparent signal. Reactions Weekly, 1472 (1) 3 doi:10.1007/s40278-013-6228-2
(2013) Genetic screening for contraceptive-induced VTE. Reactions Weekly, 1472 (1) 4 doi:10.1007/s40278-013-6229-1
(2013) Balancing postoperative risks: ulcers versus pneumonia. Reactions Weekly, 1472 (1) 4 doi:10.1007/s40278-013-6230-8
(2013) Varenicline not linked to depression, anxiety in smokers. Reactions Weekly, 1472 (1) 4 doi:10.1007/s40278-013-6231-7
(2013) Adalimumab. Reactions Weekly, 1472 (1) 5 doi:10.1007/s40278-013-6232-6
(2013) Alitretinoin. Reactions Weekly, 1472 (1) 5 doi:10.1007/s40278-013-6233-5
(2013) Acetazolamide/phenytoin. Reactions Weekly, 1472 (1) 5 doi:10.1007/s40278-013-6234-4
(2013) Aciclovir. Reactions Weekly, 1472 (1) 5 doi:10.1007/s40278-013-6235-3
(2013) Amisulpride. Reactions Weekly, 1472 (1) 6 doi:10.1007/s40278-013-6236-2
(2013) Amisulpride. Reactions Weekly, 1472 (1) 6 doi:10.1007/s40278-013-6237-1
(2013) Amiodarone/citalopram/linezolid. Reactions Weekly, 1472 (1) 6 doi:10.1007/s40278-013-6238-0
(2013) Amiodarone. Reactions Weekly, 1472 (1) 6 doi:10.1007/s40278-013-6239-z
(2013) Amlodipine. Reactions Weekly, 1472 (1) 7 doi:10.1007/s40278-013-6240-6
(2013) Antipsychotics/benzatropine/laxatives. Reactions Weekly, 1472 (1) 7 doi:10.1007/s40278-013-6241-5
(2013) Antineoplastics. Reactions Weekly, 1472 (1) 7 doi:10.1007/s40278-013-6242-4
(2013) Antineoplastics. Reactions Weekly, 1472 (1) 7 doi:10.1007/s40278-013-6243-3
(2013) Antiretrovirals/metformin. Reactions Weekly, 1472 (1) 8 doi:10.1007/s40278-013-6244-2
(2013) Antiretrovirals. Reactions Weekly, 1472 (1) 8 doi:10.1007/s40278-013-6245-1
(2013) Antituberculars. Reactions Weekly, 1472 (1) 8 doi:10.1007/s40278-013-6246-0
(2013) Benzylthiouracil. Reactions Weekly, 1472 (1) 9 doi:10.1007/s40278-013-6247-z
(2013) Asenapine. Reactions Weekly, 1472 (1) 9 doi:10.1007/s40278-013-6248-y
(2013) Azathioprine. Reactions Weekly, 1472 (1) 9 doi:10.1007/s40278-013-6249-x
(2013) Bivalirudin. Reactions Weekly, 1472 (1) 10 doi:10.1007/s40278-013-6250-4
(2013) Bevacizumab. Reactions Weekly, 1472 (1) 10 doi:10.1007/s40278-013-6251-3
(2013) Bevacizumab. Reactions Weekly, 1472 (1) 10 doi:10.1007/s40278-013-6252-2
(2013) Bevacizumab. Reactions Weekly, 1472 (1) 10 doi:10.1007/s40278-013-6253-1
(2013) Boceprevir/peginterferon-α-2b/ribavirin. Reactions Weekly, 1472 (1) 10 doi:10.1007/s40278-013-6254-0
(2013) Calcipotriol. Reactions Weekly, 1472 (1) 11 doi:10.1007/s40278-013-6255-z
(2013) Calcium polystyrene sulfonate. Reactions Weekly, 1472 (1) 11 doi:10.1007/s40278-013-6256-y
(2013) Ceftriaxone. Reactions Weekly, 1472 (1) 11 doi:10.1007/s40278-013-6257-x
(2013) Celecoxib. Reactions Weekly, 1472 (1) 11 doi:10.1007/s40278-013-6258-9
(2013) Carbamazepine. Reactions Weekly, 1472 (1) 11 doi:10.1007/s40278-013-6259-8
(2013) Cisplatin/etoposide/lenograstim. Reactions Weekly, 1472 (1) 12 doi:10.1007/s40278-013-6260-2
(2013) Cetuximab/gefitinib. Reactions Weekly, 1472 (1) 12 doi:10.1007/s40278-013-6261-1
(2013) Ciclosporin/rifampicin interaction. Reactions Weekly, 1472 (1) 12 doi:10.1007/s40278-013-6262-0
(2013) Cisplatin/fluvoxamine. Reactions Weekly, 1472 (1) 12 doi:10.1007/s40278-013-6263-z
(2013) Citalopram. Reactions Weekly, 1472 (1) 13 doi:10.1007/s40278-013-6264-y
(2013) Cisplatin/irinotecan. Reactions Weekly, 1472 (1) 13 doi:10.1007/s40278-013-6265-x
(2013) Clindamycin. Reactions Weekly, 1472 (1) 13 doi:10.1007/s40278-013-6266-9
(2013) Clarithromycin/pentamidine. Reactions Weekly, 1472 (1) 13 doi:10.1007/s40278-013-6267-8
(2013) Codeine/paracetamol. Reactions Weekly, 1472 (1) 14 doi:10.1007/s40278-013-6268-7
(2013) Clozapine. Reactions Weekly, 1472 (1) 14 doi:10.1007/s40278-013-6269-6
(2013) Clozapine. Reactions Weekly, 1472 (1) 14 doi:10.1007/s40278-013-6270-0
(2013) Colchicine overdose. Reactions Weekly, 1472 (1) 14 doi:10.1007/s40278-013-6271-z
(2013) Cotrimoxazole. Reactions Weekly, 1472 (1) 15 doi:10.1007/s40278-013-6272-y
(2013) Cotrimoxazole. Reactions Weekly, 1472 (1) 15 doi:10.1007/s40278-013-6273-x
(2013) Collagenase clostridium histolyticum. Reactions Weekly, 1472 (1) 15 doi:10.1007/s40278-013-6274-9
(2013) Cytarabine/methotrexate/vincristine. Reactions Weekly, 1472 (1) 16 doi:10.1007/s40278-013-6275-8
(2013) Dabigatran etexilate. Reactions Weekly, 1472 (1) 16 doi:10.1007/s40278-013-6276-7
(2013) Cyclophosphamide/doxorubicin/prednisolone. Reactions Weekly, 1472 (1) 16 doi:10.1007/s40278-013-6277-6
(2013) Cyclophosphamide/epirubicin. Reactions Weekly, 1472 (1) 16 doi:10.1007/s40278-013-6278-5
(2013) Dasatinib. Reactions Weekly, 1472 (1) 17 doi:10.1007/s40278-013-6279-4
(2013) Deferiprone. Reactions Weekly, 1472 (1) 17 doi:10.1007/s40278-013-6280-y
(2013) Dantrolene. Reactions Weekly, 1472 (1) 17 doi:10.1007/s40278-013-6281-x
(2013) Diazepam. Reactions Weekly, 1472 (1) 17 doi:10.1007/s40278-013-6282-9
(2013) Dibotermin-α. Reactions Weekly, 1472 (1) 18 doi:10.1007/s40278-013-6283-8
(2013) Donepezil. Reactions Weekly, 1472 (1) 18 doi:10.1007/s40278-013-6284-7
(2013) Diazoxide. Reactions Weekly, 1472 (1) 18 doi:10.1007/s40278-013-6285-6
(2013) Docetaxel. Reactions Weekly, 1472 (1) 18 doi:10.1007/s40278-013-6286-5
(2013) Estradiol/progesterone. Reactions Weekly, 1472 (1) 19 doi:10.1007/s40278-013-6287-4
(2013) Epinephrine. Reactions Weekly, 1472 (1) 19 doi:10.1007/s40278-013-6288-3
(2013) Entecavir. Reactions Weekly, 1472 (1) 19 doi:10.1007/s40278-013-6289-2
(2013) Erlotinib. Reactions Weekly, 1472 (1) 19 doi:10.1007/s40278-013-6290-9
(2013) Estrogen/leuprorelin. Reactions Weekly, 1472 (1) 20 doi:10.1007/s40278-013-6293-6
(2013) Everolimus. Reactions Weekly, 1472 (1) 20 doi:10.1007/s40278-013-6294-5
(2013) Everolimus/mitotane interaction. Reactions Weekly, 1472 (1) 20 doi:10.1007/s40278-013-6295-4
(2013) Etanercept. Reactions Weekly, 1472 (1) 20 doi:10.1007/s40278-013-6291-8
(2013) Everolimus. Reactions Weekly, 1472 (1) 20 doi:10.1007/s40278-013-6292-7
(2013) Fingolimod. Reactions Weekly, 1472 (1) 21 doi:10.1007/s40278-013-6296-3
(2013) Fentanyl/methadone. Reactions Weekly, 1472 (1) 21 doi:10.1007/s40278-013-6297-2
(2013) Factor XI. Reactions Weekly, 1472 (1) 21 doi:10.1007/s40278-013-6298-1
(2013) Flecainide overdose. Reactions Weekly, 1472 (1) 21 doi:10.1007/s40278-013-6299-0
(2013) Gabapentin. Reactions Weekly, 1472 (1) 22 doi:10.1007/s40278-013-6300-y
(2013) Fluconazole. Reactions Weekly, 1472 (1) 22 doi:10.1007/s40278-013-6301-x
(2013) Gefitinib. Reactions Weekly, 1472 (1) 22 doi:10.1007/s40278-013-6302-9
(2013) Heparin. Reactions Weekly, 1472 (1) 22 doi:10.1007/s40278-013-6303-8
(2013) Imatinib. Reactions Weekly, 1472 (1) 23 doi:10.1007/s40278-013-6304-7
(2013) Ibandronic acid. Reactions Weekly, 1472 (1) 23 doi:10.1007/s40278-013-6305-6
(2013) Ibandronic acid. Reactions Weekly, 1472 (1) 23 doi:10.1007/s40278-013-6306-5
(2013) Hyaluronidase. Reactions Weekly, 1472 (1) 23 doi:10.1007/s40278-013-6307-4
(2013) Imatinib. Reactions Weekly, 1472 (1) 24 doi:10.1007/s40278-013-6308-3
(2013) Influenza virus vaccine. Reactions Weekly, 1472 (1) 24 doi:10.1007/s40278-013-6309-2
(2013) Iodine/peginterferon-α. Reactions Weekly, 1472 (1) 24 doi:10.1007/s40278-013-6310-9
(2013) Immune globulin. Reactions Weekly, 1472 (1) 24 doi:10.1007/s40278-013-6311-8
(2013) Lenalidomide. Reactions Weekly, 1472 (1) 25 doi:10.1007/s40278-013-6312-7
(2013) Lamivudine/nevirapine/zidovudine. Reactions Weekly, 1472 (1) 25 doi:10.1007/s40278-013-6313-6
(2013) Leflunomide. Reactions Weekly, 1472 (1) 25 doi:10.1007/s40278-013-6314-5
(2013) Lamotrigine. Reactions Weekly, 1472 (1) 25 doi:10.1007/s40278-013-6315-4
(2013) Ivermectin. Reactions Weekly, 1472 (1) 25 doi:10.1007/s40278-013-6316-3
(2013) Levodopa. Reactions Weekly, 1472 (1) 26 doi:10.1007/s40278-013-6317-2
(2013) Linezolid. Reactions Weekly, 1472 (1) 26 doi:10.1007/s40278-013-6318-1
(2013) Lithium. Reactions Weekly, 1472 (1) 26 doi:10.1007/s40278-013-6319-0
(2013) Levetiracetam. Reactions Weekly, 1472 (1) 26 doi:10.1007/s40278-013-6320-7
(2013) Lithium/venlafaxine. Reactions Weekly, 1472 (1) 26 doi:10.1007/s40278-013-6321-6
(2013) Metformin. Reactions Weekly, 1472 (1) 27 doi:10.1007/s40278-013-6322-5
(2013) Metandienone. Reactions Weekly, 1472 (1) 27 doi:10.1007/s40278-013-6323-4
(2013) Mepivacaine. Reactions Weekly, 1472 (1) 27 doi:10.1007/s40278-013-6324-3
(2013) Methadone. Reactions Weekly, 1472 (1) 27 doi:10.1007/s40278-013-6325-2
(2013) Methylprednisolone/sulfasalazine. Reactions Weekly, 1472 (1) 28 doi:10.1007/s40278-013-6326-1
(2013) Methotrexate. Reactions Weekly, 1472 (1) 28 doi:10.1007/s40278-013-6327-0
(2013) Methylprednisolone acetate. Reactions Weekly, 1472 (1) 28 doi:10.1007/s40278-013-6328-z
(2013) Montelukast. Reactions Weekly, 1472 (1) 29 doi:10.1007/s40278-013-6329-y
(2013) Metoclopramide. Reactions Weekly, 1472 (1) 29 doi:10.1007/s40278-013-6330-5
(2013) Metoclopramide. Reactions Weekly, 1472 (1) 29 doi:10.1007/s40278-013-6331-4
(2013) Nabilone. Reactions Weekly, 1472 (1) 29 doi:10.1007/s40278-013-6332-3
(2013) Nadroparin calcium. Reactions Weekly, 1472 (1) 29 doi:10.1007/s40278-013-6333-2
(2013) Nimotuzumab. Reactions Weekly, 1472 (1) 30 doi:10.1007/s40278-013-6334-1
(2013) Oxymetazoline overdose. Reactions Weekly, 1472 (1) 30 doi:10.1007/s40278-013-6335-0
(2013) Parathyroid hormone. Reactions Weekly, 1472 (1) 30 doi:10.1007/s40278-013-6336-z
(2013) Oxytocin. Reactions Weekly, 1472 (1) 30 doi:10.1007/s40278-013-6337-y
(2013) Peginterferon-α-2a/ribavirin. Reactions Weekly, 1472 (1) 31 doi:10.1007/s40278-013-6338-x
(2013) Peginterferon-α-2a/ribavirin. Reactions Weekly, 1472 (1) 31 doi:10.1007/s40278-013-6339-9
(2013) Pasireotide. Reactions Weekly, 1472 (1) 31 doi:10.1007/s40278-013-6340-3
(2013) Peginterferon-α-2a. Reactions Weekly, 1472 (1) 31 doi:10.1007/s40278-013-6341-2
(2013) Perindopril. Reactions Weekly, 1472 (1) 32 doi:10.1007/s40278-013-6342-1
(2013) Piperacillin/tazobactam. Reactions Weekly, 1472 (1) 32 doi:10.1007/s40278-013-6343-0
(2013) Phenelzine abuse. Reactions Weekly, 1472 (1) 32 doi:10.1007/s40278-013-6344-z
(2013) Phenobarbital. Reactions Weekly, 1472 (1) 32 doi:10.1007/s40278-013-6345-y
(2013) Ranolazine. Reactions Weekly, 1472 (1) 33 doi:10.1007/s40278-013-6346-x
(2013) Propranolol. Reactions Weekly, 1472 (1) 33 doi:10.1007/s40278-013-6347-9
(2013) Propylthiouracil. Reactions Weekly, 1472 (1) 33 doi:10.1007/s40278-013-6348-8
(2013) Rifampicin. Reactions Weekly, 1472 (1) 33 doi:10.1007/s40278-013-6349-7
(2013) Prednisolone. Reactions Weekly, 1472 (1) 33 doi:10.1007/s40278-013-6350-1
(2013) Sufentanil. Reactions Weekly, 1472 (1) 34 doi:10.1007/s40278-013-6351-0
(2013) Rifampicin. Reactions Weekly, 1472 (1) 34 doi:10.1007/s40278-013-6352-z
(2013) Silver. Reactions Weekly, 1472 (1) 34 doi:10.1007/s40278-013-6353-y
(2013) Ritonavir/tacrolimus interaction. Reactions Weekly, 1472 (1) 34 doi:10.1007/s40278-013-6354-x
(2013) Tapentadol/various other drugs. Reactions Weekly, 1472 (1) 35 doi:10.1007/s40278-013-6355-9
(2013) Sulphur hexafluoride. Reactions Weekly, 1472 (1) 35 doi:10.1007/s40278-013-6356-8
(2013) Tamoxifen. Reactions Weekly, 1472 (1) 35 doi:10.1007/s40278-013-6357-7
(2013) Sunitinib. Reactions Weekly, 1472 (1) 35 doi:10.1007/s40278-013-6358-6
(2013) Terlipressin. Reactions Weekly, 1472 (1) 36 doi:10.1007/s40278-013-6359-5
(2013) Thalidomide. Reactions Weekly, 1472 (1) 36 doi:10.1007/s40278-013-6360-z
(2013) Terlipressin. Reactions Weekly, 1472 (1) 36 doi:10.1007/s40278-013-6361-y
(2013) Telbivudine. Reactions Weekly, 1472 (1) 36 doi:10.1007/s40278-013-6362-x
(2013) Valproic acid. Reactions Weekly, 1472 (1) 37 doi:10.1007/s40278-013-6363-9
(2013) Tramadol/paracetamol abuse. Reactions Weekly, 1472 (1) 37 doi:10.1007/s40278-013-6364-8
(2013) Topiramate. Reactions Weekly, 1472 (1) 37 doi:10.1007/s40278-013-6365-7
(2013) Thiamazole. Reactions Weekly, 1472 (1) 37 doi:10.1007/s40278-013-6366-6
(2013) Tranexamic acid. Reactions Weekly, 1472 (1) 37 doi:10.1007/s40278-013-6367-5
(2013) Zoledronic acid. Reactions Weekly, 1472 (1) 38 doi:10.1007/s40278-013-6368-4
(2013) Vancomycin. Reactions Weekly, 1472 (1) 38 doi:10.1007/s40278-013-6369-3
(2013) Warfarin. Reactions Weekly, 1472 (1) 38 doi:10.1007/s40278-013-6370-x

See Also

These are possibly similar items as determined by title/reference text matching only.

(2013, October) Reactions Weekly Vol. 1473 (1) Springer Science and Business Media LLC
(2013, October) Reactions Weekly Vol. 1474 (1) Springer Science and Business Media LLC
(2013, October) Reactions Weekly Vol. 1475 (1) Springer Science and Business Media LLC
(2019, October) Reactions Weekly Vol. 1771 (1) Springer Science and Business Media LLC
(2019, October) Reactions Weekly Vol. 1772 (1) Springer Science and Business Media LLC
(2019, October) Reactions Weekly Vol. 1773 (1) Springer Science and Business Media LLC
(2019, October) Reactions Weekly Vol. 1774 (1) Springer Science and Business Media LLC
(2019, October) Reactions Weekly Vol. 1775 (1) Springer Science and Business Media LLC
(2019, October) Reactions Weekly Vol. 1776 (1) Springer Science and Business Media LLC
(2016, October) Reactions Weekly Vol. 1621 (1) Springer Science and Business Media LLC
(2016, October) Reactions Weekly Vol. 1622 (1) Springer Science and Business Media LLC
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are © OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: August 15, 2025 07:18:22
Go to top of page